{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:45:34Z","timestamp":1782708334738,"version":"3.54.5"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012314","name":"Shinshu University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012314","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To use the RS-1 Glauvas (NIDEK) system to evaluate the effect of axial length (AL) correction on retinal thickness (RT) with optical coherence tomography (OCT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study design<\/jats:title>\n                    <jats:p>Observational, cross-sectional study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between November 2023 and April 2024, 165 eyes from patients with diabetes underwent OCT imaging. RT was measured with and without AL-based magnification correction with the Early Treatment Diabetic Retinopathy Study (ETDRS) grid, which comprises three concentric circles (diameters; 1, 3, and 6\u00a0mm), with the inner and outer rings divided into superior, temporal, nasal, and inferior sectors. Measurements were calculated using two settings: a fixed AL of 24\u00a0mm (uncorrected) and the individually measured AL for each eye (corrected). The difference between uncorrected and corrected RT measurements was analyzed using Bland\u2013Altman analysis. Linear regression analysis was performed to assess the association between AL and the measurement difference.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean AL was 23.9\u00a0\u00b1\u00a01.2\u00a0mm. Bland\u2013Altman analysis for central subfield thickness (CST) showed a small mean difference between corrected and uncorrected measurements (bias \u22120.34\u00a0\u00b5m; 95% limits of agreement \u22126.32 to 5.63\u00a0\u00b5m). Linear regression demonstrated a significant positive association between AL and the difference in CST measurements (R\n                      <jats:sup>2<\/jats:sup>\n                      \u00a0=\u00a00.70, p\u00a0&lt;\u00a00.0001), indicating that uncorrected measurements tended to underestimate and overestimate RT in eyes with shorter and longer AL, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>AL differences affect the effective OCT scan area and may influence RT measurements. Applying AL correction minimizes measurement bias caused by transverse magnification and improves the accuracy of RT assessment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10384-026-01393-6","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:19:10Z","timestamp":1782706750000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Axial length correction in retinal thickness measurements in diabetic retinopathy"],"prefix":"10.1007","author":[{"given":"Shuji","family":"Mukawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3601-8053","authenticated-orcid":false,"given":"Takao","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Chiku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Kajiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Sekiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Fujihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Tomihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Hoshiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Kakihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"1393_CR1","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","volume":"119","author":"QD Nguyen","year":"2012","unstructured":"Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L, et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology. 2012;119:789\u2013801.","journal-title":"Ophthalmology"},{"key":"1393_CR2","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.ophtha.2014.08.031","volume":"122","author":"PA Campochiaro","year":"2015","unstructured":"Campochiaro PA, Clark WL, Boyer DS, Heier JS, Brown DM, Vitti R, et al. Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT study. Ophthalmology. 2015;122:538\u201344.","journal-title":"Ophthalmology"},{"key":"1393_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ophtha.2019.04.017","volume":"127","author":"PU Dugel","year":"2020","unstructured":"Dugel PU, Koh A, Ogura Y, Jaffe GJ, Schmidt-Erfurth U, Brown DM, et al. HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration. Ophthalmology. 2020;127:72\u201384.","journal-title":"Ophthalmology"},{"key":"1393_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/BF00175988","volume":"232","author":"AG Bennett","year":"1994","unstructured":"Bennett AG, Rudnicka AR, Edgar DF. Improvements on Littmann\u2019s method of determining the size of retinal features by fundus photography. Graefes Arch Clin Exp Ophthalmol. 1994;232:361\u20137.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1393_CR5","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.18240\/ijo.2025.06.15","volume":"18","author":"H Fujihara","year":"2025","unstructured":"Fujihara H, Kakihara S, Hirano T, Murata T. Comparison of axial length measurements with RS-1 spectral domain optical coherence tomography and OA-2000 biometer. Int J Ophthalmol. 2025;18:1085\u20139.","journal-title":"Int J Ophthalmol"},{"key":"1393_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12886-018-0842-y","volume":"18","author":"Q Xu","year":"2018","unstructured":"Xu Q, Li Y, Cheng Y, Qu Y. Assessment of the effect of age on macular layer thickness in a healthy Chinese cohort using spectral-domain optical coherence tomography. BMC Ophthalmol. 2018;18:169.","journal-title":"BMC Ophthalmol"},{"key":"1393_CR7","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1055\/s-2008-1055068","volume":"180","author":"H Littmann","year":"1982","unstructured":"Littmann H. Determination of the real size of an object on the fundus of the living eye. Klin Monbl Augenheilkd. 1982;180:286\u20139 (in German).","journal-title":"Klin Monbl Augenheilkd"},{"key":"1393_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1055\/s-2008-1050076","volume":"192","author":"H Littmann","year":"1988","unstructured":"Littmann H. Determining the true size of an object on the fundus of the living eye. Klin Monbl Augenheilkd. 1988;192:66\u20137 (in German).","journal-title":"Klin Monbl Augenheilkd"},{"key":"1393_CR9","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ophtha.2023.12.026","volume":"131","author":"TY Wong","year":"2024","unstructured":"Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, et al. Faricimab treat-and-extend for diabetic macular edema: two-year results from the randomized phase 3 YOSEMITE and RHINE trials. Ophthalmology. 2024;131:708\u201323.","journal-title":"Ophthalmology"},{"key":"1393_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ajo.2023.07.012","volume":"260","author":"CC Wykoff","year":"2024","unstructured":"Wykoff CC, Garweg JG, Regillo C, Souied E, Wolf S, Dhoot DS, et al. KESTREL and KITE phase 3 studies: 100-week results with brolucizumab in patients with diabetic macular edema. Am J Ophthalmol. 2024;260:70\u201383.","journal-title":"Am J Ophthalmol"},{"key":"1393_CR11","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0140-6736(22)00010-1","volume":"399","author":"JS Heier","year":"2022","unstructured":"Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, et al. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials. Lancet. 2022;399:729\u201340.","journal-title":"Lancet"},{"key":"1393_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147782","volume":"11","author":"T Higashide","year":"2016","unstructured":"Higashide T, Ohkubo S, Hangai M, Ito Y, Shimada N, Ohno-Matsui K, et al. Influence of clinical factors and magnification correction on normal thickness profiles of macular retinal layers using optical coherence tomography. PLoS One. 2016;11:e0147782.","journal-title":"PLoS One"},{"key":"1393_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0266909","volume":"17","author":"H Niyazmand","year":"2022","unstructured":"Niyazmand H, Lingham G, Sanfilippo PG, Blaszkowska M, Franchina M, Yazar S, et al. The effect of transverse ocular magnification adjustment on macular thickness profile in different refractive errors in community-based adults. PLoS One. 2022;17:e0266909.","journal-title":"PLoS One"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-026-01393-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-026-01393-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-026-01393-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:19:11Z","timestamp":1782706751000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-026-01393-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":13,"alternative-id":["1393"],"URL":"https:\/\/doi.org\/10.1007\/s10384-026-01393-6","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"14 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S. Mukawa, None; T. Hirano, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Novartis, Bayer, Canon, Kowa, Senju, Chugai, Santen); Y. Chiku, None; S. Kajiwara, None; E. Sekiya, None; H. Fujihara, None; R. Tomihara, None; S. Ito, None; K. Hoshiyama, None; S. Kakihara, None; T. Murata, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Novartis, Bayer, Canon, Kowa, Senju, Chugai, Kyowa Kirin, Santen).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}